IP Library › Granted Patent US 11,464,961
Granted Patent B2
US 11,464,961 · App. 16/832,807 · Granted Oct 11, 2022

Needleless connector and access port disinfection cleaner and antimicrobial protection cap

Inventor: Jonathan Karl Burkholz (Salt Lake City, UT)
Assignee: Becton, Dickinson and Company
A61M39/162A61M5/001A61M39/16A61M39/20A61M5/31
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,464,961
App. No.
16/832,807
Granted
Oct 11, 2022
Kind
B2
Abstract

A protective cap having a first cap and a second cap that are removably coupled together for use in short-term and long-term antimicrobial treatment of needleless connectors and access ports of an infusion system. The instant invention further provides a protective cap having a first cap and a second cap that each coupled to a different surface of a component of an infusion system, such as a syringe. The instant invention further provides a strip containing a plurality of disposable protective caps.

Claims (25)

1. A method for antiseptically maintaining a patient fluid line access valve, the method comprising:

providing a syringe having a volume filled with a fluid for injection, the syringe having a nozzle coupled to a first cap; the first cap having a first end and a second end, the first end comprising a first opening having a first pad disposed therein; wherein the first end is sealed by a removable lid covering the first opening;

removing the removable lid covering thereby exposing the first opening;

engaging the first opening to the patient fluid line access valve, thereby contacting the first pad to at least a portion of the patient fluid line access valve;

disinfecting at least the portion of the patient fluid line access valve;

disengaging the first cap from the syringe nozzle by unthreading the first cap from the syringe;

connecting the nozzle of the syringe to the patient fluid line access valve;

injecting some of the fluid for injection through the patient fluid line access valve; and

after injecting some of the fluid for injection through the patient fluid line access valve, removing a second cap from a plunger of the syringe and coupling the second cap to the nozzle, wherein the second cap comprises a second pad containing an antimicrobial solution.

2. The method of claim 1 , wherein the removable lid comprises at least one of a foil lidding material and a polymer lidding material.

3. The method of claim 1 , wherein the first opening is configured to receive an access portion of a patient fluid line access valve, wherein the pad comprises an exterior surface that extends across the first opening and a cylindrical cut extending into the exterior surface to divide the pad into a central, cylindrical cutout and a surrounding portion, wherein when the central, cylindrical cutout is uncompressed, the exterior surfaces of the central, cylindrical cutout and the surrounding portion form an uneven surface, and wherein when the access portion is inserted into the first opening, the central, cylindrical cutout compresses to displace the exterior surface of the central, cylindrical cutout from the exterior surface of the surrounding portion thereby forming a central cavity within the pad.

4. The method of claim 3 , wherein the first opening includes a set of threads that is configured to receive a compatible set of threads on the access portion of the patient fluid line access valve.

5. The method of claim 1 , wherein the pad contains an antimicrobial solution and the disinfecting step includes contacting the antimicrobial solution to the portion of the patient fluid line access valve.

6. The method of claim 5 , wherein the antimicrobial solution comprises a wet solution selected from at least one of a first antimicrobial agent from approximately 0.01% to approximately 10.0% (v/v), and an alcohol from approximately 50% to approximately 99.99% (v/v).

7. The method of claim 6 , wherein the antimicrobial agent is selected from the group consisting of chlorhexidine acetate, chlorhexidine gluconate, PVP-I, Triclosan, PCMX, BEC, BAC, antibiotic, Octinidine, and suitable salts thereof.

8. The method of claim 5 , wherein the antimicrobial solution comprises a wet, water-based solution, comprising:

an antimicrobial agent from approximately 0.01% to approximately 10.0% (v/v);

an alcohol solvent from approximately 1% to approximately 10% (v/v); and

water from approximately 90% to approximately 99% (v/v).

9. The method of claim 1 , wherein the disengaging step occurs prior to the removing step.

10. The method of claim 1 , wherein the steps occur in the order stated.

11. The method of claim 1 , wherein injection step comprises injecting the entire volume of fluid for injection contained within the syringe through the patient fluid line access valve.

12. The method of claim 11 , wherein injection step comprises injecting a portion of the volume of fluid for injection contained within the syringe through the patient fluid line access valve.

13. The method of claim 12 , further comprising providing a second cap for engagement to the nozzle of the syringe, wherein the second cap is configured to sealingly engage the nozzle thereby containing an un-injected volume of fluid for injection.

14. The method of claim 13 , further comprising removing the second cap from a plunger of the syringe.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2020
From: BURKHOLZ, JONATHAN KARL
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 052616/0554 →
Continuity (3)
Continuation 15216307 · Jul 21, 2016
Continuation 13766540 · Feb 13, 2013
Related Publication 20200222682A1 · Jul 16, 2020